Table 2.
Prevalence of MetS and its components among T2DM patients in relation to hyperuricemia (n = 314)
| Variable | N (%) | Hyperuricemia N (%) | Normouricaemia N (%) | Mean ± SD | P-value |
|---|---|---|---|---|---|
| MetS | 220(70.1) | 87(27.7) | 133(42.4) | 26.4 ± 10.1 | 0.001 |
| WC ≥ 102 for male, ≥ 88 cm for female | 193(61.3) | 40(12.7) | 153(48.7) | 93.6 ± 18.1 | 0.0001 |
| TG ≥ 150 mg/dl | 221(70.4) | 98(31.2) | 123(39.2) | 202.5 ± 89.8 | 0.0001 |
| Low HDL-C, (< 40 mg/dl for males, < 50 mg/dl for females) | 123(39.2) | 38(12.1) | 85(27.1) | 54.9 ± 59.2 | 0.4 |
| FBS > 110 mg/dl | 252(80.0) | 92(29.3) | 160(50.6) | 200 ± 100 | 0.04 |
| SBP > 130 mmHg | 85(27.1) | 49(15.6) | 36(11.5) | 123.6 ± 14.3 | 0.0001 |
| DBP > 85 mmHg | 88(28.0) | 40(12.7) | 48(15.3) | 79.2 ± 9.2 | 0.006 |
BMI:body mass index; FBS:fasting blood sugar; HDL-C:high density lipoprotein cholesterol,; WC: waist circumference